-+ 0.00%
-+ 0.00%
-+ 0.00%

INMUNE BIO - ENGAGES U.S. REGULATORY ADVISORS FOR TYPE B MEETING REQUEST TO FDA

Reuters·10/21/2026 11:15:11

Please log in to view news